Dr. Messay Balcha, MD

Dr. Balcha practices at Inova Physician Partners in Falls Church, Virginia.

Dr. Balcha's NPI, 1821155094, was assigned on January 3, 2007. Dr. Balcha holds Virginia license 0101840506.

Dr. Balcha's primary practice is Inova Physician Partners, at 6565 Arlington Blvd, Falls Church, VA 22042 in Fairfax County. The practice phone is (703) 321-2609.

Dr. Balcha's primary practice is Inova Physician Partners in Falls Church, Virginia. Dr. Balcha is also affiliated with Inova Fairfax Hospital. The medical group on file is Inova Urgent Care Center. Dmand AI also links Dr. Balcha to 3 more hospitals, 1 community health center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Balcha practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Balcha's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Balcha is licensed in Virginia.

CMS data shows 614 Medicare services from Dr. Balcha across 9 procedure codes in 2024, for 185 Medicare patients. Medicare paid $60,130 for them. Every service was in an office.

CMS counts 185 Medicare patients who saw Dr. Balcha in 2024. The largest group is 65 to 74, with 91 patients. 74% of them have high blood pressure, and 72% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Balcha's median patient age at 56, with 43% women.

In 2024, Dr. Balcha wrote 4,543 Medicare Part D claims for 383 patients. 83% of them were for generic drugs. CMS names the drug for 3,776 of them, across 75 drugs with 11 or more claims each, at $404,438 in total drug cost. In 2023, CMS named 2,776 claims across 60 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Balcha for performance year 2024, reported through an alternative payment model (APM). Dr. Balcha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Balcha as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Balcha from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $115.